相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。Progression of fatigue in Parkinson's disease - a 9-year follow-up
S. O. Ongre et al.
EUROPEAN JOURNAL OF NEUROLOGY (2021)
Fatigue Is Common and Predicted by Female Gender and Sleep Disturbance in Patients with Chronic Spontaneous Urticaria
Kemal Erol et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE (2021)
Safety and efficacy of amantadine, modafinil, and methylphenidate for fatigue in multiple sclerosis: a randomised, placebo-controlled, crossover, double-blind trial
Bardia Nourbakhsh et al.
LANCET NEUROLOGY (2021)
Minimal Clinically Important Differences for Measures of Pain, Lung Function, Fatigue, and Functionality in Spinal Cord Injury
Margarida Sobreira et al.
PHYSICAL THERAPY (2021)
Fatigue in inflammatory bowel disease and its impact on daily activities
Philipp Schreiner et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2021)
Non-pharmacological interventions for fatigue in older adults: a systematic review and meta-analysis
Lily Y. W. Ho et al.
AGE AND AGEING (2020)
IMPACT OF LEMBOREXANT ON INSOMNIA DISEASE SEVERITY AND FATIGUE IN ELDERLY SUBJECTS WITH INSOMNIA FROM SUNRISE-2
Jane Yardley et al.
AMERICAN JOURNAL OF GERIATRIC PSYCHIATRY (2020)
Long-term efficacy and tolerability of lemborexant compared with placebo in adults with insomnia disorder: results from the phase 3 randomized clinical trial SUNRISE 2
Mikko Karppa et al.
SLEEP (2020)
Residual symptoms after natural remission of insomnia: associations with relapse over 4 years
Xiaowen Ji et al.
SLEEP (2019)
Minimally important difference of the fatigue severity scale and modified fatigue impact scale in people with multiple sclerosis
Scott Rooney et al.
MULTIPLE SCLEROSIS AND RELATED DISORDERS (2019)
Fatigue, Sleep, and Autoimmune and Related Disorders
Mark R. Zielinski et al.
FRONTIERS IN IMMUNOLOGY (2019)
Factors associated with fatigue in patients with insomnia
Seog Ju Kim et al.
JOURNAL OF PSYCHIATRIC RESEARCH (2019)
Comparison of Lemborexant With Placebo and Zolpidem Tartrate Extended Release for the Treatment of Older Adults With Insomnia Disorder A Phase 3 Randomized Clinical Trial
Russell Rosenberg et al.
JAMA NETWORK OPEN (2019)
Insomnia in the Elderly: A Review
Dhaval Patel et al.
JOURNAL OF CLINICAL SLEEP MEDICINE (2018)
The Orexin/Receptor System: Molecular Mechanism and Therapeutic Potential for Neurological Diseases
Chunmei Wang et al.
FRONTIERS IN MOLECULAR NEUROSCIENCE (2018)
Clinical Practice Guideline for the Pharmacologic Treatment of Chronic Insomnia in Adults: An American Academy of Sleep Medicine Clinical Practice Guideline
Michael J. Sateia et al.
JOURNAL OF CLINICAL SLEEP MEDICINE (2017)
In Vitro and In Silico Characterization of Lemborexant (E2006), a Novel Dual Orexin Receptor Antagonist
Carsten Theodor Beuckmann et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2017)
Fatigue as a symptom or comorbidity of neurological diseases
Iris-Katharina Penner et al.
Nature Reviews Neurology (2017)
Validity and reliability of the Fatigue Severity Scale in Finnish multiple sclerosis patients
Eija Rosti-Otajarvi et al.
BRAIN AND BEHAVIOR (2017)
Orexin Receptor Antagonists: New Therapeutic Agents for the Treatment of Insomnia
Anthony J. Roecker et al.
JOURNAL OF MEDICINAL CHEMISTRY (2016)
Fatigue and depression in multiple sclerosis: pharmacological and non-pharmacological interventions
P. Brenner et al.
ACTA NEUROLOGICA SCANDINAVICA (2016)
Minimal important differences for fatigue patient reported outcome measures-a systematic review
Asa Nordin et al.
BMC MEDICAL RESEARCH METHODOLOGY (2016)
Hypothalamic Dysfunction and Multiple Sclerosis: Implications for Fatigue and Weight Dysregulation
Kevin G. Burfeind et al.
CURRENT NEUROLOGY AND NEUROSCIENCE REPORTS (2016)
Emerging role of orexin antagonists in insomnia therapeutics: An update on SORAs and DORAs
Anil Kumar et al.
PHARMACOLOGICAL REPORTS (2016)
Pharmacological treatments for fatigue associated with palliative care: executive summary of a Cochrane Collaboration systematic review
Martin Muecke et al.
JOURNAL OF CACHEXIA SARCOPENIA AND MUSCLE (2016)
The neurobiology, investigation, and treatment of chronic insomnia
Dieter Riemann et al.
LANCET NEUROLOGY (2015)
Lifestyle habits and fatigue among people with systemic lupus erythematosus and matched population controls
S. Pettersson et al.
LUPUS (2015)
Cognitive Behavioral Therapy for Insomnia Comorbid With Psychiatric and Medical Conditions A Meta-analysis
Jade Q. Wu et al.
JAMA INTERNAL MEDICINE (2015)
Discovery and development of orexin receptor antagonists as therapeutics for insomnia
C. J. Winrow et al.
BRITISH JOURNAL OF PHARMACOLOGY (2014)
Reward responsiveness and fatigue in multiple sclerosis
Matteo Pardini et al.
MULTIPLE SCLEROSIS JOURNAL (2013)
Health perceptions and clinical characteristics of relapsing-remitting multiple sclerosis patients: baseline data from an international clinical trial
D. Robinson et al.
CURRENT MEDICAL RESEARCH AND OPINION (2009)
Orexin/Hypocretin: A Neuropeptide at the Interface of Sleep, Energy Homeostasis, and Reward System
N. Tsujino et al.
PHARMACOLOGICAL REVIEWS (2009)
Efficacy of an insomnia intervention on fatigue, mood and quality of life in breast cancer survivors
Shannon R. Dirksen et al.
JOURNAL OF ADVANCED NURSING (2008)
Determination of the minimal clinically important difference for seven fatigue measures in rheumatoid arthritis
Jacques Pouchot et al.
JOURNAL OF CLINICAL EPIDEMIOLOGY (2008)
Validation of the Fatigue Severity Scale in a Swiss Cohort
Philipp O. Valko et al.
SLEEP (2008)
Dysfunctional beliefs and attitudes about sleep (DBAS):: Validation of a brief version (DBAS-16)
Charles M. Morin et al.
SLEEP (2007)
Promotion of sleep by targeting the orexin system in rats, dogs and humans
Catherine Brisbare-Roch et al.
NATURE MEDICINE (2007)
Functional neuroimaging evidence for hyperarousal in insomnia
EA Nofzinger et al.
AMERICAN JOURNAL OF PSYCHIATRY (2004)
Insomnia and daytime functioning
BW Riedel et al.
SLEEP MEDICINE REVIEWS (2000)